Search research articles
Contact Us
Filters
Showing results (201-210 of 253) with videos related to
Page
of 26
Sort By:
Leukemia & Lymphoma
|
January 8, 2025
Variance in development of early and late cardiotoxicities in patients with lymphoma and myeloma receiving CAR T-cell therapies
Eli Grunblatt, Zhiying Meng, Abigail S Baldridge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2021
Single-Agent Ibrutinib for Rituximab-Refractory Waldenström Macroglobulinemia: Final Analysis of the Substudy of the Phase III Innovate<sup>TM</sup> Trial
Judith Trotman, Christian Buske, Alessandra Tedeschi, et al.
Journal of Ethnopharmacology
|
September 22, 2018
Comparative comprehension on the anti-rheumatic Chinese herbal medicine Siegesbeckiae Herba: Combined computational predictions and experimental investigations
Qian Ru Zhang, Zhang Feng Zhong, Wei Sang, et al.
Leukemia & Lymphoma
|
August 2, 2021
A phase I/II trial of brentuximab vedotin plus rituximab as frontline therapy for patients with immunosuppression-associated CD30+ and/or EBV + lymphomas
William B Pearse, Adam M Petrich, Leo I Gordon, et al.
Blood Advances
|
September 27, 2023
Ibrutinib maintenance after frontline treatment in patients with mantle cell lymphoma
Reem Karmali, Jeremy S Abramson, Deborah M Stephens, et al.
Oncogene
|
April 3, 2025
Phosphorylation enhanced OTUD3 deubiquitination ARID3A promotes the progress of cholangiocarcinoma
Deng-Yong Zhang, Yan Zhu, Shuo-Shuo Ma, et al.
Journal of Pharmaceutical Analysis
|
April 15, 2024
Small molecule deoxynyboquinone triggers alkylation and ubiquitination of Keap1 at Cys489 on Kelch domain for Nrf2 activation and inflammatory therapy
Ke-Gang Linghu, Tian Zhang, Guang-Tao Zhang, et al.
Blood Advances
|
January 18, 2024
A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen
Reem Karmali, Carlos Galvez, Mehdi Hamadani, et al.
NPJ Digital Medicine
|
January 26, 2026
Multimodal digital biopsy for preoperative prediction of occult peritoneal metastasis in gastric cancer
Sheng Chen, Ping'an Ding, Yihao Yang, et al.
Blood
|
February 8, 2017
Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma
Ariela Noy, Sven de Vos, Catherine Thieblemont, et al.
Page
of 26
Search research articles
Search
Showing results (201-210 of 253) with videos related to
Sort By:
Page
of 26
Leukemia & Lymphoma
|
January 8, 2025
Variance in development of early and late cardiotoxicities in patients with lymphoma and myeloma receiving CAR T-cell therapies
Eli Grunblatt, Zhiying Meng, Abigail S Baldridge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2021
Single-Agent Ibrutinib for Rituximab-Refractory Waldenström Macroglobulinemia: Final Analysis of the Substudy of the Phase III Innovate<sup>TM</sup> Trial
Judith Trotman, Christian Buske, Alessandra Tedeschi, et al.
Journal of Ethnopharmacology
|
September 22, 2018
Comparative comprehension on the anti-rheumatic Chinese herbal medicine Siegesbeckiae Herba: Combined computational predictions and experimental investigations
Qian Ru Zhang, Zhang Feng Zhong, Wei Sang, et al.
Leukemia & Lymphoma
|
August 2, 2021
A phase I/II trial of brentuximab vedotin plus rituximab as frontline therapy for patients with immunosuppression-associated CD30+ and/or EBV + lymphomas
William B Pearse, Adam M Petrich, Leo I Gordon, et al.
Blood Advances
|
September 27, 2023
Ibrutinib maintenance after frontline treatment in patients with mantle cell lymphoma
Reem Karmali, Jeremy S Abramson, Deborah M Stephens, et al.
Oncogene
|
April 3, 2025
Phosphorylation enhanced OTUD3 deubiquitination ARID3A promotes the progress of cholangiocarcinoma
Deng-Yong Zhang, Yan Zhu, Shuo-Shuo Ma, et al.
Journal of Pharmaceutical Analysis
|
April 15, 2024
Small molecule deoxynyboquinone triggers alkylation and ubiquitination of Keap1 at Cys489 on Kelch domain for Nrf2 activation and inflammatory therapy
Ke-Gang Linghu, Tian Zhang, Guang-Tao Zhang, et al.
Blood Advances
|
January 18, 2024
A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen
Reem Karmali, Carlos Galvez, Mehdi Hamadani, et al.
NPJ Digital Medicine
|
January 26, 2026
Multimodal digital biopsy for preoperative prediction of occult peritoneal metastasis in gastric cancer
Sheng Chen, Ping'an Ding, Yihao Yang, et al.
Blood
|
February 8, 2017
Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma
Ariela Noy, Sven de Vos, Catherine Thieblemont, et al.
Page
of 26